We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Ring-Shaped Device Reduces Pain of Drawing Blood

By HospiMedica International staff writers
Posted on 16 Dec 2010
A single use ring that fits around the middle finger allows quick and effective drawing of blood without need of a medical professional. More...


The Rapid Ring is an integrated device for sampling and testing blood from a human finger, comprised of a radially expandable, temporary clamp placed around the distal phalanx of the middle finger, a spring-loaded lancet for piercing the fingertip, and a testing platform for studying the blood sample directly after being drawn. The ring-type clamp applies pressure to the finger to create a region of increased blood volume and pressure, reducing the pain of the lancet. The close proximity of the device's components could also be an effective solution to the problem of drawing enough blood from the patient's finger.

The housing also contains a lateral opening for inserting the test strip, which has a small orifice on its surface to allow the lancet to pierce through it so that blood drawn automatically drips onto the strip. An optional capillary sponge can further facilitate the transfer of the sample to the test strip, which contains a predetermined amount of at least one reagent testing means. A blood volume window indicates when sufficient blood has been drawn for a particular test, and a second window indicates the test results.

The disposable device is intended for early detection of diseases and complications from AIDS; diagnosing health conditions such as elevated cholesterol; measuring glucose levels for monitoring diabetes; detecting the presence of illegal drugs and drugs of abuse; screening for pregnancy; measuring prothrombin time for monitoring blood thinning and clotting; detecting fecal occult blood to screen for colorectal cancer; and detecting luteinizing hormone to predict ovulation. The Rapid Ring is a product of RapidDX (Tel Aviv, Israel), a portfolio company of TechnoPlus Ventures (Tel Aviv, Israel), and has been approved by the US Food and Drug Administration (FDA).

Related Links:

TechnoPlus Ventures




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gold Member
Electrode Solution and Skin Prep
Signaspray
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.